Beijing Weili New Century Science & Technology Development

Beijing Weili New Century Science & Technology Development is a Chinese medical device company focused on the development, manufacture, and commercialization of hospital equipment used primarily in andrology, urology, infectious disease, liver disease, digestive care, endocrinology, and related specialties. The company markets a portfolio of commercial devices including sperm quality analysis systems, erectile dysfunction shock wave therapy systems, prostate therapy devices, semen collection and erectile function analysis systems, blood purification and artificial liver support systems, and ascites ultrafiltration/reinfusion equipment. Weili appears to operate as a commercial-stage device manufacturer rather than a therapeutics developer, with products already sold to hospitals across China and some international markets. The business emphasizes domestic medical equipment innovation, particularly in male health and blood purification/artificial liver support, and has also conducted distributor and export activity. The company was formerly quoted on China's National Equities Exchange and Quotations system before delisting in April 2025.